Inventor · disambiguated record
Mi Deng
Also filed as: Deng mi
7 granted patents·3 pending applications·13 citations·filing 2015–2025
77Inventor score
Top patents by PatentIndex Score
10 records- 0188US10501538B2Anti-LILRB antibodies and their use in detecting and treating cancerUNIV TEXAS·Filed 2017·Granted Dec 10, 2019·5 cites·24 claims
- 0287US10370643B2LILRB2 and notch-mediated expansion of hematopoietic precursor cellsHUTCHINSON FRED CANCER RES·Filed 2015·Granted Aug 6, 2019·5 cites·19 claims
- 0385US12202895B2LILRB4 antibodies and uses thereofUNIV TEXAS·Filed 2019·Granted Jan 21, 2025·2 cites·42 claims
- 0468US11377491B2Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancerUNIV TEXAS·Filed 2018·Granted Jul 5, 2022·1 cites·10 claims
- 0567US2025250336A1Novel lilrb4 antibodies and uses thereofUNIV TEXAS·Filed 2025·Application pending·0 cites
- 0665US11498963B2Anti-LILRB antibodies and their use in detecting and treating cancerUNIV TEXAS·Filed 2019·Granted Nov 15, 2022·0 cites·15 claims
- 0757US2019330593A1Lilrb2 and notch-mediated expansion of hematopoietic precursor cellsHUTCHINSON FRED CANCER RES·Filed 2019·Application pending·0 cites
- 0852US11906519B2Methods for identifying LILRB-blocking antibodiesUNIV TEXAS·Filed 2017·Granted Feb 20, 2024·0 cites·26 claims
- 0952US2024101667A1Methods for identifying lilrb-blocking antibodiesUNIV TEXAS·Filed 2021·Application pending·0 cites
- 1041US11013704B2Compounds supports hematopoietic stem cells and red blood cellsUNIV TEXAS·Filed 2015·Granted May 25, 2021·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Mi Deng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →